A Phase 3 interventional study of Fluoride free toothpaste in a chalk base and Fluoride Toothpaste in Demineralization, Remineralization and Dental Cavity, sponsored by Colgate Palmolive. Completed at 1 site in Brazil. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-06.
Sponsored by Colgate Palmolive · Phase 3, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 82 studies in Dental Caries with a site in Brazil — 5 open to participants now, 6 under way, none of them phase 3. Dental Caries · Brazil.
Among the 82 studies in Dental Caries with a site in Brazil, this one is the 60th largest by enrollment of the 79 interventional ones that give a count, is one of 2 that started in 2025, is one of 6 in phase 3, and was the 80th registered.
1,175 studies on the registry are indexed under Dental Caries; 209 are open to participants now.
Browse Dental Caries studies →5 of the 82 studies in Dental Caries with a site in Brazil are open now. Recruiting first, the newest first:
University of Nove de Julho · Sites in Brazil
Ages 6–12 · Healthy volunteers
Universidade Federal de Goias · Sites in Brazil
Ages 1–7 · Healthy volunteers
Federal University of Pelotas · Sites in Brazil
Ages 7–11 · Healthy volunteers
University of Sao Paulo · Sites in Brazil
Ages 4–8
DMG Dental Material Gesellschaft mbH · Sites in Brazil, Portugal
Ages 4–8
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
82 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 3 · Phase 3 7 · Phase 4 4
First in 2001; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 36 is below the median of 60 across 967 interventional studies indexed under Dental Caries.
Median enrollment 119 across the 79 interventional studies, 200 across the 3 observational. Of the 50 that completed or were terminated, 2 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 82 have an industry lead sponsor. The 10 most frequent:
Colgate Palmolive is the lead sponsor of 120 studies on the registry; 14 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.
Colgate Palmolive has 8 studies filed under Dental Caries — fewer than ten, so there is no comparison to draw.
1 of the studies in Dental Caries with a site in Brazil that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05965297DMG Dental Material Gesellschaft mbHComparison of Two GIC's in the Restoration of Posterior Class II Lesions in the Primary Dentition | 2027-08 |
Add it to your calendar (.ics) → With an account.
Among the 82 studies in Dental Caries with a site in Brazil, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Clinical study to evaluate the anti-cavity effectiveness of three dentrifices using an intra-oral enamel Demineralization and Remineralization In-Situ Model. This is a six-week duration, Phase III, single-center, triple-blind crossover study. Thirty-six healthy adults will be randomly allocated to three groups for the treatment phases, which are interspersed with washout periods.
This Phase III, randomized, triple-blind, crossover study will assess the anti-cavity effectiveness of three different dentrifices. Thirty-six participants, aged 18-70, will use an intra-oral appliance. For six weeks, they will be divided into three treatment groups and instructed to brush twice daily with one of the following: one using a fluoride-free toothpaste with a chalk base and herbal ingredients, another using a fluoride toothpaste containing 1000 ppm MFP and 1.5% arginine in a PCC/RNCC base, and a negative control group using a fluoride-free toothpaste in a PCC/RNCC base. Each participant will receive a soft-bristle toothbrush and the toothpastes assigned.
Between each five-day treatment phase, participants will have a nine-day washout period, using a fluoride-free toothpaste in a PCC/RNCC base. The study's eight-visit schedule includes a baseline visit, three treatment phases, three washout periods interspersed between the treatment phases, and a final visit. The primary outcome will be the measurement of changes in enamel microhardness, with assessments taking place both before and after each treatment to determine the impact on the enamel. The expected outcome is the confirmation of the alternative hypothesis, which predicts a reduction in the percentage of mineral loss from the surface of bovine enamel after using dentifrices containing 1000 ppm MFP with 1.5% arginine or herbal ingredients for five days each, compared to the control group. The percentage of mineral loss on the tooth surface relative to baseline will be used to quantify the extent of reduction in enamel demineralization. A two factor ANCOVA using the baseline as the covariate will be conducted to determine if a significant treatment effect exists. Adverse events and compliance will be closely monitored, with strict confidentiality maintained for all participants.
Inclusion Criteria: Potential subjects must meet ALL of the following criteria:
Exclusion Criteria: Potential subjects must NOT HAVE ANY of the following conditions:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects will brush using a fluoride free toothpaste in a chalk base with herbal ingredients and a soft bristle toothbrush
Drug: Fluoride free toothpaste in a chalk base · Device: Toothbrush
Subjects will brush using a fluoride toothpaste containing 1000 ppm MFP and 1.5% arginine in a PCC/RNCC base and a soft bristle toothbrush
Drug: Fluoride Toothpaste · Device: Toothbrush
Subjects will brush using a fluoride free toothpaste in a PCC/RNCC base and a soft bristle toothbrush
Drug: Fluoride free toothpaste in a PCC/RNCC base · Device: Toothbrush
Subjects will brush using a fluoride free toothpaste in a PCC/RNCC base and a soft bristle toothbrush for 9 days, between the treatment phases.
Drug: Fluoride free toothpaste in a PCC/RNCC base · Device: Toothbrush
Fluoride free toothpaste in a chalk base with herbal ingredients
Fluoride toothpaste containing 1000 ppm MFP and 1.5% arginine in a PCC/RNCC base
Fluoride free toothpaste in a PCC/RNCC base
A commercially available adult soft bristle toothbrush
Microhardness change
The primary outcome of this study will be the change in the hardness of an intra-oral appliance before and after treatment. It will be determined by measuring the length of an indentation made on the appliance, which in turn allows for the calculation of its hardness value. The effectiveness of the treatment in reducing enamel demineralization by quantifying the percentage of mineral loss relative to the baseline will also be assessed.
Time frame: 6 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2025 to primary completion in Dec 2025, 2 months.
Of 18 phase 3 interventional studies under Dental Caries, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 26. This study's 2 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.